Effects of Clarithromycin combined with Tiotropium Bromide for the levels of procalcitonin, C reactive protein in elderly patients with acute exacerbation of chronic obstructive pulmonary disease
XU Yinghui1 LI Xiang1 XU Dan2
1.Department of Respiratory, Fushun Central Hospital, Liaoning Province, Fushun 113006, China;
2.Department of Science and Education, Fushun Central Hospital, Liaoning Province, Fushun 113006, China
Abstract:Objective To observe the effects of Clarithromycin combined with Tiotropium Bromide for the levels of procalcitonin, C reactive protein in elderly patients with acute exacerbation of chronic obstructive pulmonary disease (COPD). Methods Sixty elderly patients with acute exacerbation of COPD treated in Fushun Central Hospital of Liaoning Province from October 2014 to January 2015 were selected and randomly divided into observation group and control group, with 30 cases in each group. The control group received Tiotropium Bromide Dry Powder Inhalation, on basis of which, the observation group received Clarithromycin orally. The improvement of levels of procalcitonin, C reactive protein and lung function [forced expiratory volume in the first second (FEV1), the percentage of forced expiratory volume in the first second accounted for forced vital capacity (FEV1/FVC)] and the conditions of side effects of the two groups were observed and compared. Results There were statistically significant differences of effects between groups, time effects and interaction effects of procalcitonin, C reactive protein in the two groups (P < 0.05). After treatment for 10, 20 d, the levels of procalcitonin, C reactive protein in the two groups were all lower than those on admission, which after treatment for 20 d were lower than those after treatment for 10 d, the differences were all statistically significant (P < 0.05). After treatment for 10, 20 d, the levels of procalcitonin, C reactive protein in the observation group were significantly lower than those of control group (P < 0.05). After treatment, the levels of FEV1, FEV1/FVC in the two groups were all higher than those before treatment (P < 0.05), which of observation group was higher than that of control group (P < 0.05). Both groups had no serious adverse reactions. Conclusion Clarithromycin combined with Tiotropium Bromide has significant effects on the levels of procalcitonin and C reactive protein expression in elderly patients with acute exacerbation of COPD, which can improve the pulmonary function of patients, thus it is worthy of promotion and application in clinic.
许迎辉1 李响1 徐丹2. 克拉霉素联合噻托溴铵对老年慢性阻塞性肺疾病患者急性加重期降钙素原、C反应蛋白水平的影响[J]. 中国医药导报, 2017, 14(32): 137-140,155.
XU Yinghui1 LI Xiang1 XU Dan2. Effects of Clarithromycin combined with Tiotropium Bromide for the levels of procalcitonin, C reactive protein in elderly patients with acute exacerbation of chronic obstructive pulmonary disease. 中国医药导报, 2017, 14(32): 137-140,155.